CAPRICOR THERAPEUTICS, INC. Current Assets
CAPRICOR THERAPEUTICS, INC. (CAPR) had Current Assets of $242.13 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $242.13M.
- 2026-03-31: Assets, Current $283.09M.
- 2025-12-31: Assets, Current $322.94M.
- 2025-09-30: Assets, Current $100.95M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $242.13M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $283.09M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $322.94M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $100.95M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $124.13M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $146.25M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $163.39M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $85.82M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $30.67M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $41.41M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $50.86M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $29.53M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $38.92M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $46.59M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $42.89M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $47.50M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $52.62M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $59.63M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $36.44M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $41.30M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $38.73M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $42.62M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $33.68M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $35.49M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $36.55M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $13.77M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $10.54M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $7.29M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $6.64M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $7.90M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $8.47M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $11.39M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $13.54M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $14.61M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $15.71M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $15.23M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $13.64M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $13.46M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $18.11M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $22.40M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $11.81M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $14.89M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $13.99M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $17.71M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $21.64M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $25.42M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $11.61M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $14.20M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $16.41M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $14.03M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $3.68M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $109.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $289.29K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $404.28K 10-Q · filed 2013-06-21 | |
| 2012-12-31 | $5.19M 10-K · filed 2014-03-31 | $171.63K 10-K · filed 2013-06-21 |
| 2012-09-30 | $438.35K 10-Q · filed 2013-06-21 | |
| 2012-06-30 | $941.85K 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $656.12K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.31M 10-Q · filed 2013-06-21 | |
| 2011-09-30 | $3.03M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.64M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $3.60M 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |